查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1604619

適體市場：按產品、應用和最終用戶分類 - 全球預測 2025-2030

Aptamers Market by Product (Nucleotide Based, Peptide Based), Application (Diagnostics, Research & Development, Therapeutics Development), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年適配體市場價值為13.4億美元，預計2024年將達到14.8億美元，年複合成長率為10.91%，預計到2030年將達到27.7億美元。

適體是短的單鏈核酸或胜肽，與抗體類似，以高親和性和特異性結合特定標靶分子。它們採用體外製程合成，可實現快速且經濟高效的生產。由於適體的穩定性、低免疫抗原性以及可設計用於多種功能的能力，對適體的需求涵蓋多種應用，這使得它們在治療應用、診斷和生物感測器開發中至關重要。最終用途包括製藥、生物技術、環境監測和食品安全等領域，其中適體在疾病治療、生物標記發現、污染物檢測等方面發揮作用。該市場在很大程度上是由分子生物學的進步以及由於其更高的穩定性和更低的生產成本而相對於傳統抗體越來越偏愛適配體來推動的。此外，對標靶治療和個人化醫療的需求不斷增加，以及基於適配體的診斷工具的開發，以滿足因 COVID-19 大流行而激增的就地檢驗需求，將進一步刺激成長。適體在藥物傳遞系統中的廣泛應用已經成熟，以提高治療方法的精確度。然而，市場成長受到一些挑戰的限制，例如來自現有抗體技術的競爭、適體穩定性和體內遞送的技術問題以及監管障礙。創新在於增強適體選擇技術、改善體內遞送機制、開發基於適體的多功能奈米結構。適配體市場的本質是動態的，其特點是技術快速進步以及生物技術公司和研究機構之間旨在提高適配體功能的合作。公司可以透過策略聯盟和研發投資來解決當前的限制並滿足診斷和治療應用的新需求，從而抓住機會。

主要市場統計
基準年[2023] 13.4億美元
預測年份 [2024] 14.8億美元
預測年份 [2030] 27.7億美元
複合年成長率（%） 10.91%

市場動態：揭示快速發展的適體市場的關鍵市場洞察

供需的動態交互作用正在改變適配體市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 投資藥物開發和使用適體進行藥物結合親和性
    • 政府鼓勵個人化醫療和治療的舉措
    • 基於適體的生物感測器和照護現場診斷的不斷發展
  • 市場限制因素
    • 對適體半衰期短的擔憂
  • 市場機會
    • 適體生產與功能的技術進步
    • 適體在食品安全與真實性檢測的新興應用
  • 市場挑戰
    • 開發複雜性和監管限制

波特五力：駕馭適體市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解外部對適體市場的影響

外部宏觀環境因素在塑造適配體市場的表現動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助企業預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解適配體市場競爭狀況

適配體市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣適體市場供應商績效評估

FPNV定位矩陣是評估適配體市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議 規劃適配體市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，適體市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 投資藥物開發並利用適體實現藥物結合親和性
      • 政府鼓勵個人化醫療和治療的舉措
      • 基於適體的生物感測器和照護現場的開發進展
    • 抑制因素
      • 對適體半衰期短的擔憂
    • 機會
      • 適體生產與功能的技術進步
      • 適體在食品安全與真偽檢測的應用
    • 任務
      • 開發複雜性和監管限制
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章適體市場：依產品

  • 核苷酸鹼基
    • DNA
    • RNA
    • XNA
  • 基於胜肽的

第7章適體市場：依應用分類

  • 診斷
  • 研究與開發
  • 治療藥物開發

第 8 章適體市場：依最終使用者分類

  • 學術和政府研究機構
  • 生物技術和製藥公司
  • 合約調查機構

第9章 美洲適體市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太地區適配體市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東和非洲適配體市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Zentek 和 McMaster 宣布 aptamer 平台有正面成果
    • Aptamer Group 與 NeuroBio 合作開發阿茲海默症診斷測試
    • 推出免疫組織化學新試劑解決方案“Optimer-Fc”
    • 新設施開幕以滿足對適體和最佳化器技術不斷成長的需求
  • 戰略分析和建議

公司名單

  • 2bind GmbH
  • Agilent Technologies, Inc.
  • Aptagen, LLC
  • Aptamer Group
  • Aptamer Sciences, Inc.
  • AptaTargets SL
  • Aptus Biotech SL
  • ATDBio Ltd.
  • Base Pair Biotechnologies, Inc.
  • Basking Biosciences
  • Cage Bio, Inc.
  • Creative Biogene
  • Drive Therapeutics, LLC
  • IVERIC bio, Inc.
  • Kaneka Corporation
  • Maravai LifeSciences
  • Mediomics, LLC
  • NeoVentures Biotechnology, Inc.
  • NOVAPTECH
  • Novartis AG
  • Qualigen, Inc.
  • Raptamer Discovery Group
  • SomaLogic, Inc.
  • TAGCyx Biotechnologies Inc.
  • Vivonics, Inc.
Product Code: MRR-4358BACA838E

The Aptamers Market was valued at USD 1.34 billion in 2023, expected to reach USD 1.48 billion in 2024, and is projected to grow at a CAGR of 10.91%, to USD 2.77 billion by 2030.

Aptamers are short, single-stranded nucleic acids or peptides that bind to specific target molecules with high affinity and specificity, similar to antibodies. They are synthesized through in vitro processes, allowing for rapid and cost-effective production. The necessity of aptamers spans across various applications due to their stability, low immunogenicity, and ability to be engineered for diverse functions, making them pivotal in therapeutic applications, diagnostics, and biosensor development. End-use includes sectors such as pharmaceuticals, biotechnology, environmental monitoring, and food safety, where aptamers play roles in disease treatment, biomarker discovery, and contaminant detection. The market is largely driven by ongoing advancements in molecular biology and a growing preference for aptamers over traditional antibodies due to their increased stability and lower production costs. Also, the rise in demand for targeted therapies and personalized medicine further stimulates growth, along with developments in aptamer-based diagnostic tools responding to the surge in point-of-care testing needs due to the COVID-19 pandemic. Opportunities are ripe in expanding aptamer applications in drug delivery systems, where they enhance the precision of treatment modalities. However, market growth is restrained by challenges such as competition from well-established antibody technologies, technical issues related to the stability and delivery of aptamers in vivo, and regulatory hurdles. Innovation lies in enhancing aptamer selection technologies, improving in vivo delivery mechanisms, and developing multifunctional aptamer-based nanostructures. The nature of the aptamer market is dynamic, characterized by rapid technological advancements and partnerships between biotech firms and research institutions aiming to improve aptamer functionalities. Businesses can capitalize on opportunities through strategic collaborations and investing in R&D to address current limitations and meet emerging demands in diagnostics and therapeutic applications.

KEY MARKET STATISTICS
Base Year [2023] USD 1.34 billion
Estimated Year [2024] USD 1.48 billion
Forecast Year [2030] USD 2.77 billion
CAGR (%) 10.91%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Aptamers Market

The Aptamers Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Investments in drug development and use of aptamers for drug-binding affinity
    • Government initiatives encouraging personalized medicine and treatment
    • Rising development of aptamer-based biosensors and point-of-care diagnostics
  • Market Restraints
    • Concerns associated with short half-life of aptamers
  • Market Opportunities
    • Technological advancements in aptamer production and functionalities
    • Emergence use of aptamers for food safety and authenticity testing
  • Market Challenges
    • Development complexity and regulatory limitations

Porter's Five Forces: A Strategic Tool for Navigating the Aptamers Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Aptamers Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Aptamers Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Aptamers Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Aptamers Market

A detailed market share analysis in the Aptamers Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Aptamers Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Aptamers Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Aptamers Market

A strategic analysis of the Aptamers Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Aptamers Market, highlighting leading vendors and their innovative profiles. These include 2bind GmbH, Agilent Technologies, Inc., Aptagen, LLC, Aptamer Group, Aptamer Sciences, Inc., AptaTargets SL, Aptus Biotech S.L., ATDBio Ltd., Base Pair Biotechnologies, Inc., Basking Biosciences, Cage Bio, Inc., Creative Biogene, Drive Therapeutics, LLC, IVERIC bio, Inc., Kaneka Corporation, Maravai LifeSciences, Mediomics, LLC, NeoVentures Biotechnology, Inc., NOVAPTECH, Novartis AG, Qualigen, Inc., Raptamer Discovery Group, SomaLogic, Inc., TAGCyx Biotechnologies Inc., and Vivonics, Inc..

Market Segmentation & Coverage

This research report categorizes the Aptamers Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Nucleotide Based and Peptide Based. The Nucleotide Based is further studied across DNA, RNA, and XNA.
  • Based on Application, market is studied across Diagnostics, Research & Development, and Therapeutics Development.
  • Based on End-User, market is studied across Academic & Government Research Institutes, Biotechnology & Pharmaceutical Companies, and Contract Research Organizations.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Investments in drug development and use of aptamers for drug-binding affinity
      • 5.1.1.2. Government initiatives encouraging personalized medicine and treatment
      • 5.1.1.3. Rising development of aptamer-based biosensors and point-of-care diagnostics
    • 5.1.2. Restraints
      • 5.1.2.1. Concerns associated with short half-life of aptamers
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in aptamer production and functionalities
      • 5.1.3.2. Emergence use of aptamers for food safety and authenticity testing
    • 5.1.4. Challenges
      • 5.1.4.1. Development complexity and regulatory limitations
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Aptamers Market, by Product

  • 6.1. Introduction
  • 6.2. Nucleotide Based
    • 6.2.1. DNA
    • 6.2.2. RNA
    • 6.2.3. XNA
  • 6.3. Peptide Based

7. Aptamers Market, by Application

  • 7.1. Introduction
  • 7.2. Diagnostics
  • 7.3. Research & Development
  • 7.4. Therapeutics Development

8. Aptamers Market, by End-User

  • 8.1. Introduction
  • 8.2. Academic & Government Research Institutes
  • 8.3. Biotechnology & Pharmaceutical Companies
  • 8.4. Contract Research Organizations

9. Americas Aptamers Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Aptamers Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Aptamers Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Zentek and McMaster Announce Positive Results for the Aptamer Platform
    • 12.3.2. Aptamer Group and Neuro-Bio Collaborate to Develop Alzheimer's Disease Diagnostic Test
    • 12.3.3. Launch of Optimer-Fc as a New Reagent Solution for Immunohistochemistry
    • 12.3.4. Aptamer Opens New Facilities to Meet Growing Demand for Optimer Technology
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 2bind GmbH
  • 2. Agilent Technologies, Inc.
  • 3. Aptagen, LLC
  • 4. Aptamer Group
  • 5. Aptamer Sciences, Inc.
  • 6. AptaTargets SL
  • 7. Aptus Biotech S.L.
  • 8. ATDBio Ltd.
  • 9. Base Pair Biotechnologies, Inc.
  • 10. Basking Biosciences
  • 11. Cage Bio, Inc.
  • 12. Creative Biogene
  • 13. Drive Therapeutics, LLC
  • 14. IVERIC bio, Inc.
  • 15. Kaneka Corporation
  • 16. Maravai LifeSciences
  • 17. Mediomics, LLC
  • 18. NeoVentures Biotechnology, Inc.
  • 19. NOVAPTECH
  • 20. Novartis AG
  • 21. Qualigen, Inc.
  • 22. Raptamer Discovery Group
  • 23. SomaLogic, Inc.
  • 24. TAGCyx Biotechnologies Inc.
  • 25. Vivonics, Inc.

LIST OF FIGURES

  • FIGURE 1. APTAMERS MARKET RESEARCH PROCESS
  • FIGURE 2. APTAMERS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL APTAMERS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL APTAMERS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL APTAMERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL APTAMERS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL APTAMERS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL APTAMERS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL APTAMERS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL APTAMERS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL APTAMERS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS APTAMERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS APTAMERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES APTAMERS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES APTAMERS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC APTAMERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC APTAMERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA APTAMERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA APTAMERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. APTAMERS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. APTAMERS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. APTAMERS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL APTAMERS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL APTAMERS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL APTAMERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. APTAMERS MARKET DYNAMICS
  • TABLE 7. GLOBAL APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL APTAMERS MARKET SIZE, BY DNA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL APTAMERS MARKET SIZE, BY RNA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL APTAMERS MARKET SIZE, BY XNA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL APTAMERS MARKET SIZE, BY PEPTIDE BASED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL APTAMERS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL APTAMERS MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL APTAMERS MARKET SIZE, BY THERAPEUTICS DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL APTAMERS MARKET SIZE, BY ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL APTAMERS MARKET SIZE, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL APTAMERS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS APTAMERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES APTAMERS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC APTAMERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA APTAMERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 190. APTAMERS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 191. APTAMERS MARKET, FPNV POSITIONING MATRIX, 2023